These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 1354999

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of administration of cholecystokinin into the VTA on DA overflow in nucleus accumbens and amygdala of freely moving rats.
    Hamilton ME, Freeman AS.
    Brain Res; 1995 Aug 07; 688(1-2):134-42. PubMed ID: 8542299
    [Abstract] [Full Text] [Related]

  • 4. Cellular localization of tyrosine hydroxylase mRNA and cholecystokinin mRNA-containing cells in the ventral mesencephalon of the common marmoset: effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Sirinathsinghji DJ, Kupsch A, Mayer E, Zivin M, Pufal D, Oertel WH.
    Brain Res Mol Brain Res; 1992 Jan 07; 12(1-3):267-74. PubMed ID: 1347634
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Infusions of cholecystokinin octapeptide into the ventral tegmental area potentiate amphetamine conditioned place preferences.
    Pettit HO, Mueller K.
    Psychopharmacology (Berl); 1989 Jan 07; 99(3):423-6. PubMed ID: 2594910
    [Abstract] [Full Text] [Related]

  • 7. Cholecystokinin increases extracellular dopamine overflow in the anterior nucleus accumbens via CCK(B) receptors in the VTA assessed by in vivo voltammetry.
    Reum T, Schäfer U, Marsden CA, Fink H, Morgenstern R.
    Neuropeptides; 1997 Feb 07; 31(1):82-8. PubMed ID: 9574843
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of long-term haloperidol treatment on the responsiveness of accumbens neurons to cholecystokinin and dopamine: electrophysiological and radioligand binding studies in the rat.
    Debonnel G, Gaudreau P, Quirion R, de Montigny C.
    J Neurosci; 1990 Feb 07; 10(2):469-78. PubMed ID: 2137531
    [Abstract] [Full Text] [Related]

  • 10. Differences in behavioural effects of amphetamine and dopamine-related gene expression in wild-type and homozygous CCK2 receptor deficient mice.
    Rünkorg K, Värv S, Matsui T, Kõks S, Vasar E.
    Neurosci Lett; 2006 Oct 02; 406(1-2):17-22. PubMed ID: 16916582
    [Abstract] [Full Text] [Related]

  • 11. Cholecystokinin modulation of locomotor behavior in rats is sensitized by chronic amphetamine and chronic restraint stress exposure.
    Wunderlich GR, Rotzinger S, Bush DE, DeSousa NJ, Vaccarino FJ.
    Brain Res; 2004 Mar 19; 1001(1-2):95-107. PubMed ID: 14972658
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Electrical stimulation of the prefrontal cortex increases cholecystokinin, glutamate, and dopamine release in the nucleus accumbens: an in vivo microdialysis study in freely moving rats.
    You ZB, Tzschentke TM, Brodin E, Wise RA.
    J Neurosci; 1998 Aug 15; 18(16):6492-500. PubMed ID: 9698337
    [Abstract] [Full Text] [Related]

  • 14. Repeated ventral tegmental area amphetamine administration alters dopamine D1 receptor signaling in the nucleus accumbens.
    Hu XT, Koeltzow TE, Cooper DC, Robertson GS, White FJ, Vezina P.
    Synapse; 2002 Sep 01; 45(3):159-70. PubMed ID: 12112395
    [Abstract] [Full Text] [Related]

  • 15. Cholecystokinin and neurotensin mRNAs are differentially expressed in subnuclei of the ventral tegmental area.
    Jayaraman A, Nishimori T, Dobner P, Uhl GR.
    J Comp Neurol; 1990 Jun 08; 296(2):291-302. PubMed ID: 2358538
    [Abstract] [Full Text] [Related]

  • 16. Nucleus accumbens cholecystokinin (CCK) can either attenuate or potentiate amphetamine-induced locomotor activity: evidence for rostral-caudal differences in accumbens CCK function.
    Vaccarino FJ, Rankin J.
    Behav Neurosci; 1989 Aug 08; 103(4):831-6. PubMed ID: 2765186
    [Abstract] [Full Text] [Related]

  • 17. Locally application of amphetamine into the ventral tegmental area enhances dopamine release in the nucleus accumbens and the medial prefrontal cortex through noradrenergic neurotransmission.
    Pan WH, Sung JC, Fuh SM.
    J Pharmacol Exp Ther; 1996 Aug 08; 278(2):725-31. PubMed ID: 8768724
    [Abstract] [Full Text] [Related]

  • 18. Overflow of dopamine and cholecystokinin in rat nucleus accumbens in response to acute drug administration.
    Hamilton ME, Redondo JL, Freeman AS.
    Synapse; 2000 Dec 01; 38(3):238-42. PubMed ID: 11020226
    [Abstract] [Full Text] [Related]

  • 19. Extracellular dopamine in the anterior nucleus accumbens is distinctly affected by ventral tegmental area administration of cholecystokinin and apomorphine: data from in vivo voltammetry.
    Reum T, Fink H, Marsden CA, Morgenstern R.
    Neuropeptides; 1998 Apr 01; 32(2):161-6. PubMed ID: 9639255
    [Abstract] [Full Text] [Related]

  • 20. Balance of glutamate and dopamine in the nucleus accumbens modulates self-stimulation behavior after injection of cholecystokinin and neurotensin in the rat brain.
    Heidbreder C, Gewiss M, De Mot B, Mertens I, De Witte P.
    Peptides; 1992 Apr 01; 13(3):441-9. PubMed ID: 1523160
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.